Literature DB >> 2942172

von Willebrand factor contaminating porcine factor VIII concentrate (Hyate:C) causes platelet aggregation.

D C Altieri, A M Capitanio, P M Mannucci.   

Abstract

Severe thrombocytopenia has been reported to occur in some patients treated with a polyelectrolyte-fractionated porcine factor VIII concentrate (Hyate:C) (Kernoff et al, 1984; Gatti & Mannucci, 1984). We report here that Hyate:C induces aggregation of platelet-rich plasma in vitro accompanied by ATP release and thromboxane B2 formation, and is inhibited by EDTA and prostaglandin E1. Hyate:C induced platelet aggregation is affected by monoclonal antibodies anti-glycoprotein Ib or anti-glycoprotein IIb/IIIa and suppressed by polyclonal anti-porcine von Willebrand factor antiserum. We conclude that the aggregating ability of Hyate:C is due to porcine von Willebrand factor present in the concentrate. The occasional thrombocytopenia described after Hyate:C infusions probably results from the interaction between platelets and the porcine von Willebrand factor contaminating the concentrate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942172     DOI: 10.1111/j.1365-2141.1986.tb07554.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice.

Authors:  Dipak S Pisal; Matthew P Kosloski; C Russell Middaugh; Richard B Bankert; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2012-03-02       Impact factor: 3.534

2.  Crossreactivity of Human versus Swine Platelet Surface Antigens Is Similar for Glycoproteins Ib and IIIa, but Not for the Glycoprotein IIb/IIIa Complex.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

Review 3.  Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection.

Authors:  Guerard W Byrne; Agnes M Azimzadeh; Mohamed Ezzelarab; Henry D Tazelaar; Burcin Ekser; Richard N Pierson; Simon C Robson; David K C Cooper; Christopher G A McGregor
Journal:  Xenotransplantation       Date:  2013 Sep-Oct       Impact factor: 3.907

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.